Cas no 945953-41-3 (4-(2-oxoethyl)-1-Piperazinecarboxylic acid 1,1-dimethylethyl ester)
4-(2-oxoethyl)-1-Piperazinecarboxylic acid 1,1-dimethylethyl ester Chemical and Physical Properties
Names and Identifiers
-
- 4-(2-oxoethyl)-1-Piperazinecarboxylic acid 1,1-dimethylethyl ester
- 4-(2-Oxo-ethyl)-piperazine-1-carboxylic acid tert-butyl ester
- tert-butyl 4-(2-oxoethyl)piperazine-1-carboxylate
- FT-0731116
- 945953-41-3
- tert-butyl 4-(formylmethyl)piperazine-1-carboxylate
- TERT-BUTYL4-(2-OXOETHYL)PIPERAZINE-1-CARBOXYLATE
- 1-Boc-4-(2-oxoethyl)piperazine
- DTXSID80587480
- tert-butyl 4-(2-oxoethyl)piperazine-l-carboxylate
- CS-0109761
- KGXKHDJWDRHJSH-UHFFFAOYSA-N
- SCHEMBL1498905
- DB-079965
-
- MDL: MFCD09832218
- Inchi: 1S/C11H20N2O3/c1-11(2,3)16-10(15)13-6-4-12(5-7-13)8-9-14/h9H,4-8H2,1-3H3
- InChI Key: KGXKHDJWDRHJSH-UHFFFAOYSA-N
- SMILES: O(C(N1CCN(CC=O)CC1)=O)C(C)(C)C
Computed Properties
- Exact Mass: 228.14739250g/mol
- Monoisotopic Mass: 228.14739250g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 5
- Heavy Atom Count: 16
- Rotatable Bond Count: 5
- Complexity: 252
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.5
- Topological Polar Surface Area: 49.8?2
4-(2-oxoethyl)-1-Piperazinecarboxylic acid 1,1-dimethylethyl ester Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X48505-1g |
tert-Butyl 4-(2-oxoethyl)piperazine-1-carboxylate |
945953-41-3 | 97% | 1g |
¥5160.0 | 2023-09-05 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X48505-100mg |
tert-Butyl 4-(2-oxoethyl)piperazine-1-carboxylate |
945953-41-3 | 97% | 100mg |
¥1148.0 | 2023-09-05 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X48505-250mg |
tert-Butyl 4-(2-oxoethyl)piperazine-1-carboxylate |
945953-41-3 | 97% | 250mg |
¥1721.0 | 2023-09-05 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-YQ746-200mg |
4-(2-oxoethyl)-1-Piperazinecarboxylic acid 1,1-dimethylethyl ester |
945953-41-3 | 97% | 200mg |
1581.0CNY | 2021-07-14 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-YQ746-50mg |
4-(2-oxoethyl)-1-Piperazinecarboxylic acid 1,1-dimethylethyl ester |
945953-41-3 | 97% | 50mg |
632.0CNY | 2021-07-14 | |
| Chemenu | CM530566-50mg |
tert-Butyl 4-(2-oxoethyl)piperazine-1-carboxylate |
945953-41-3 | 97% | 50mg |
$114 | 2022-08-31 | |
| Chemenu | CM530566-100mg |
tert-Butyl 4-(2-oxoethyl)piperazine-1-carboxylate |
945953-41-3 | 97% | 100mg |
$149 | 2022-08-31 | |
| Chemenu | CM530566-250mg |
tert-Butyl 4-(2-oxoethyl)piperazine-1-carboxylate |
945953-41-3 | 97% | 250mg |
$222 | 2022-08-31 | |
| Chemenu | CM530566-1g |
tert-Butyl 4-(2-oxoethyl)piperazine-1-carboxylate |
945953-41-3 | 97% | 1g |
$547 | 2022-08-31 | |
| Crysdot LLC | CD11006427-1g |
tert-Butyl 4-(2-oxoethyl)piperazine-1-carboxylate |
945953-41-3 | 97% | 1g |
$673 | 2024-07-19 |
4-(2-oxoethyl)-1-Piperazinecarboxylic acid 1,1-dimethylethyl ester Related Literature
-
Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
-
2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
-
Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
-
Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
-
Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
Additional information on 4-(2-oxoethyl)-1-Piperazinecarboxylic acid 1,1-dimethylethyl ester
4-(2-oxoethyl)-1-Piperazinecarboxylic acid 1,1-dimethylethyl ester (CAS No. 945953-41-3): A Comprehensive Overview
4-(2-oxoethyl)-1-Piperazinecarboxylic acid 1,1-dimethylethyl ester (CAS No. 945953-41-3) is a specialized chemical compound that has garnered significant attention in the pharmaceutical and organic synthesis industries. This compound, often referred to as a piperazine derivative, is widely utilized as a key intermediate in the synthesis of various bioactive molecules. Its unique structural features, including the 2-oxoethyl and 1,1-dimethylethyl ester groups, make it a versatile building block for drug discovery and development.
The growing interest in 4-(2-oxoethyl)-1-Piperazinecarboxylic acid 1,1-dimethylethyl ester can be attributed to its role in the development of novel therapeutic agents. Researchers are particularly intrigued by its potential applications in designing central nervous system (CNS) drugs, given the piperazine moiety's ability to enhance blood-brain barrier penetration. Recent studies have explored its utility in creating neuroprotective agents and psychoactive pharmaceuticals, aligning with current trends in mental health research and neurodegenerative disease treatment.
From a chemical perspective, CAS 945953-41-3 exhibits several noteworthy properties. The compound typically appears as a white to off-white crystalline powder with moderate solubility in common organic solvents. Its molecular structure combines the reactivity of an oxoethyl group with the stability provided by the tert-butyl ester protection, making it particularly valuable for multi-step synthetic routes. These characteristics have made it a popular choice for medicinal chemistry applications, especially in fragment-based drug design approaches.
The synthesis of 4-(2-oxoethyl)-1-Piperazinecarboxylic acid tert-butyl ester typically involves protection-deprotection strategies, with the tert-butyl group serving as a temporary protecting group for the carboxylic acid functionality. This approach allows for selective modification of other reactive sites in the molecule, a technique that has become increasingly important in modern drug discovery pipelines. The compound's stability under various reaction conditions has made it a reliable intermediate in the preparation of more complex pharmaceutical targets.
In the current pharmaceutical landscape, there is growing demand for piperazine-containing compounds like 945953-41-3, driven by their diverse biological activities. The compound's structural features are particularly relevant to the development of GPCR-targeting drugs, a hot topic in drug discovery circles. Its application extends to the synthesis of potential treatments for conditions ranging from psychiatric disorders to cardiovascular diseases, reflecting the broad therapeutic potential of this chemical scaffold.
Quality control and analytical characterization of 4-(2-oxoethyl)-1-Piperazinecarboxylic acid 1,1-dimethylethyl ester are crucial aspects of its commercial production. Advanced techniques such as HPLC, NMR spectroscopy, and mass spectrometry are routinely employed to ensure high purity standards. These analytical methods are particularly important given the compound's role as a pharmaceutical intermediate, where even minor impurities could significantly impact downstream applications.
The commercial availability of CAS 945953-41-3 has expanded in recent years to meet growing research demands. Suppliers typically offer the compound in various quantities, from milligram-scale for exploratory research to kilogram quantities for industrial-scale applications. Storage recommendations generally include protection from moisture and maintenance at controlled temperatures to preserve the compound's stability over extended periods.
From an environmental and safety perspective, proper handling procedures for 4-(2-oxoethyl)-1-Piperazinecarboxylic acid tert-butyl ester should be followed, including the use of appropriate personal protective equipment. While not classified as highly hazardous, standard laboratory precautions are recommended when working with this organic compound. These considerations align with the pharmaceutical industry's increasing focus on green chemistry principles and workplace safety standards.
The future outlook for 945953-41-3 appears promising, with ongoing research exploring novel applications in drug development. Its structural versatility continues to attract interest from medicinal chemists working on next-generation therapeutics. As the pharmaceutical industry places greater emphasis on structure-activity relationships and molecular diversity, compounds like this piperazine derivative are likely to remain valuable tools in the drug discovery process.
In conclusion, 4-(2-oxoethyl)-1-Piperazinecarboxylic acid 1,1-dimethylethyl ester represents an important building block in modern organic and medicinal chemistry. Its unique combination of functional groups and synthetic utility ensures its continued relevance in pharmaceutical research. As scientific understanding of piperazine-based compounds deepens, the applications for this specific derivative are expected to expand, potentially contributing to breakthroughs in therapeutic development across multiple disease areas.
945953-41-3 (4-(2-oxoethyl)-1-Piperazinecarboxylic acid 1,1-dimethylethyl ester) Related Products
- 143238-38-4(Tert-Butyl piperazine-1-carboxylate acetate)
- 219509-79-2(1-Tert-Butyl 4-methyl piperazine-1,4-dicarboxylate)
- 239066-69-4(1-Piperazinecarboxylicacid, 4-(hydroxymethyl)-, 1,1-dimethylethyl ester)
- 76535-75-6(1,4-Di-tert-butyl piperazine-1,4-dicarboxylate)
- 57260-71-6(N-Boc-piperazine)
- 76003-29-7(tert-butyl 3-oxopiperazine-1-carboxylate)
- 219509-82-7(1-Boc-4-ethoxycarbonyl Piperazine)
- 53788-49-1(N-Boc-N-methylpiperazine)
- 194350-95-3(1-Piperazinecarboxylicacid, 4-ethyl-3-oxo-, 1,1-dimethylethyl ester)
- 192130-34-0(tert-butyl 4-(2-aminoethyl)piperazine-1-carboxylate)